Fintel Plc (AIM:FNTL)
| Market Cap | 191.19M -13.4% |
| Revenue (ttm) | 87.80M +10.7% |
| Net Income | 5.10M -17.7% |
| EPS | 0.05 -17.7% |
| Shares Out | 104.19M |
| PE Ratio | 37.49 |
| Forward PE | 12.52 |
| Dividend | 0.04 (2.10%) |
| Ex-Dividend Date | Sep 24, 2026 |
| Volume | 209,673 |
| Open | 180.00 |
| Previous Close | 179.00 |
| Day's Range | 180.00 - 184.50 |
| 52-Week Range | 155.00 - 275.00 |
| Beta | 0.60 |
| Analysts | Strong Buy |
| Price Target | 330.75 (+80.25%) |
| Est. Earnings | Dec 16, 2026 |
About Fintel
Fintel Plc engages in the provision of fintech and support services to the retail financial services sector in the United Kingdom. It operates through two segments, Software & Data and Services. The Software & Data segment provides intermediary software, financial product and market data, and product research and ratings; as well as marketing, sponsorships, and consultancy to financial institutions. The Services segment provides regulatory and business support and integrated financial technology; manage distribution and market research and insi... [Read more]
Financial Performance
In 2025, Fintel's revenue was 85.90 million, an increase of 9.71% compared to the previous year's 78.30 million. Earnings were 6.30 million, an increase of 6.78%.
Financial StatementsAnalyst Summary
According to 4 analysts, the average rating for FNTL stock is "Strong Buy." The 12-month stock price target is 331p, which is an increase of 80.25% from the latest price.
News
JP Morgan Upgrades Mercury Systems to Overweight from Neutral
Fintel reports that on November 11, 2026, JP Morgan upgraded their outlook for Mercury Systems (NASDAQGS:MRCY) (BMV:MRCY) from Neutral to Overweight.
Jefferies Initiates Coverage of JBT Marel with Hold Rating
Fintel reports that on November 11, 2026, Jefferies initiated coverage of JBT Marel (NYSE:JBTM) (XTRA:JBT) with a Hold recommendation.
Jefferies Initiates Coverage of Zebra Technologies with Buy
Fintel reports that on November 11, 2026, Jefferies initiated coverage of Zebra Technologies (NASDAQGS:ZBRA) (LSE:0ACG) with a Buy recommendation.
Ladenburg Thalmann Upgrades Gladstone Investment to Buy from Neutral
Fintel reports that on November 11, 2026, Ladenburg Thalmann upgraded their outlook for Gladstone Investment (NASDAQGS:GAIN) (LSE:0IVR) from Neutral to Buy.
Piper Sandler Initiates Coverage of CareDx at Overweight
Fintel reports that on November 11, 2026, Piper Sandler initiated coverage of CareDx (NASDAQGM:CDNA) (DB:1K9) with a Overweight recommendation.
Cadeler A Consensus Price Target Lowered by 73.92% to $8.59
The average one-year price target for Cadeler A (NYSE:CDLR) (DB:CA21) has been revised to $8.59 / share. This is a decrease of 73.92% from the prior estimate of $32.92 dated November 1, 2026. These fi...
JP Morgan Upgrades Unum Group - Corporate Bond to Overweight from Neutral
Fintel reports that on November 9, 2026, JP Morgan upgraded their outlook for Unum Group - Corporate Bond (NYSE:UNMA) from Neutral to Overweight.
UBS Upgrades Southern Copper to Neutral from Sell
Fintel reports that on November 10, 2026, UBS upgraded their outlook for Southern Copper (NYSE:SCCO) (LSE:0L8B) from Sell to Neutral. This rating action follows a prior action on October 8, 2026, when...
Materion Consensus Price Target Decreased by 12.92% to $269.79
The average one-year price target for Materion (NYSE:MTRN) (DB:BEM) has been revised to $269.79 / share. This is a decrease of 12.92% from the prior estimate of $309.82 dated October 30, 2026. These f...
Cantor Fitzgerald Initiates Coverage of Amer Sports at Overweight
Fintel reports that on November 10, 2026, Cantor Fitzgerald initiated coverage of Amer Sports (NYSE:AS) (DB:483) with a Overweight recommendation.
QuinStreet Consensus Price Target Raised 14.67% to $26.32
The average one-year price target for QuinStreet (NASDAQGS:QNST) (DB:5Q8) has been revised to $26.32 / share. This is an increase of 14.67% from the prior estimate of $22.95 dated October 30, 2026. Th...
Stifel Initiates Coverage of City Therapeutics with Buy
Fintel reports that on November 10, 2026, Stifel initiated coverage of City Therapeutics (NASDAQGM:CTY) with a Buy recommendation. This rating action was officially recorded on November 10, 2026, for ...
Goldman Sachs Initiates Coverage of City Therapeutics at Early-Stage Biotech
Fintel reports that on November 10, 2026, Goldman Sachs initiated coverage of City Therapeutics (NASDAQGM:CTY) with a Early-Stage Biotech recommendation.
Enviri Consensus Price Target Increased by 10.47% to $32.30
The average one-year price target for Enviri (NYSE:NVRI) (DB:Y6U) has been revised to $32.30 / share. This is an increase of 10.47% from the prior estimate of $29.24 dated October 30, 2026. These figu...
Stevanato Group S.p.A. Consensus Price Target Decreased by 21.06% to $20.22
The average one-year price target for Stevanato Group S.p.A. (NYSE:STVN) (DB:87N) has been revised to $20.22 / share. This is a decrease of 21.06% from the prior estimate of $25.62 dated October 30, 2...
Franklin Covey Consensus Price Target Lowered by 15.93% to $26.58
The average one-year price target for Franklin Covey (NYSE:FC) has been revised to $26.58 / share. This is a decrease of 15.93% from the prior estimate of $31.62 dated October 30, 2026. These figures ...
Alarm.com Holdings Consensus Price Target Increased by 10.52% to $71.46
The average one-year price target for Alarm.com Holdings (NASDAQGS:ALRM) (LSE:0HC2) has been revised to $71.46 / share. This is an increase of 10.52% from the prior estimate of $64.66 dated October 30...
Vertex Consensus Price Target Raised 20.43% to $21.04
The average one-year price target for Vertex (NASDAQGM:VERX) (LSE:0A3L) has been revised to $21.04 / share. This is an increase of 20.43% from the prior estimate of $17.47 dated October 30, 2026. Thes...
Amplitude Consensus Price Target Increased by 38.46% to $21.70
The average one-year price target for Amplitude (NASDAQCM:AMPL) (DB:7I9) has been revised to $21.70 / share. This is an increase of 38.46% from the prior estimate of $15.67 dated October 30, 2026. The...
Modine Manufacturing Consensus Price Target Lowered by 17.84% to $255.03
The average one-year price target for Modine Manufacturing (NYSE:MOD) (DB:MMF) has been revised to $255.03 / share. This is a decrease of 17.84% from the prior estimate of $310.39 dated October 30, 20...
Seaport Global Upgrades Fox to Buy from Neutral
Fintel reports that on November 9, 2026, Seaport Global upgraded their outlook for Fox (NASDAQGS:FOX) (LSE:0A0Y) from Neutral to Buy. This rating action follows a prior action by Seaport Global on Aug...
NPK International Consensus Price Target Lowered by 17.50% to $16.83
The average one-year price target for NPK International (NYSE:NPKI) (DB:NWP) has been revised to $16.83 / share. This is a decrease of 17.50% from the prior estimate of $20.40 dated October 30, 2026. ...
Phoenix Education Partners Consensus Price Target Lowered by 33.77% to $26.94
The average one-year price target for Phoenix Education Partners (NYSE:PXED) has been revised to $26.94 / share. This is a decrease of 33.77% from the prior estimate of $40.67 dated October 30, 2026. ...
Unity Software Consensus Price Target Raised 15.24% to $59.63
The average one-year price target for Unity Software (NYSE:U) (DB:US3) has been revised to $59.63 / share. This is an increase of 15.24% from the prior estimate of $51.75 dated October 30, 2026. These...
Federal Home Loan Mortgage Consensus Price Target Cut by 52.00% to $4.59
The average one-year price target for Federal Home Loan Mortgage (OTCPK:FMCC) (LSE:0IKZ) has been revised to $4.59 / share. This is a decrease of 52.00% from the prior estimate of $9.56 dated October ...